Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients.
Sooriakumaran P, Srivastava A, Shariat SF, Stricker PD, Ahlering T, Eden CG, Wiklund PN, Sanchez-Salas R, Mottrie A, Lee D, Neal DE, Ghavamian R, Nyirady P, Nilsson A, Carlsson S, Xylinas E, Loidl W, Seitz C, Schramek P, Roehrborn C, Cathelineau X, Skarecky D, Shaw G, Warren A, Delprado WJ, Haynes AM, Steyerberg E, Roobol MJ, Tewari AK. Sooriakumaran P, et al. Among authors: nyirady p. Eur Urol. 2014 Sep;66(3):450-6. doi: 10.1016/j.eururo.2013.11.018. Epub 2013 Nov 24. Eur Urol. 2014. PMID: 24290695
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.
Tschirdewahn S, Reis H, Niedworok C, Nyirady P, Szendröi A, Schmid KW, Shariat SF, Kramer G, vom Dorp F, Rübben H, Szarvas T. Tschirdewahn S, et al. Among authors: nyirady p. Urol Oncol. 2014 Jul;32(5):663-9. doi: 10.1016/j.urolonc.2014.02.004. Epub 2014 May 9. Urol Oncol. 2014. PMID: 24814404
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.
Lucca I, Kassouf W, Kapoor A, Fairey A, Rendon RA, Izawa JI, Black PC, Fajkovic H, Seitz C, Remzi M, Nyirády P, Rouprêt M, Margulis V, Lotan Y, de Martino M, Hofbauer SL, Karakiewicz PI, Briganti A, Novara G, Shariat SF, Klatte T. Lucca I, et al. Among authors: nyirady p. BJU Int. 2015 Jul;116(1):72-8. doi: 10.1111/bju.12801. Epub 2015 Mar 6. BJU Int. 2015. PMID: 24825476
Current State of ERG as Biomarker in Prostatic Adenocarcinoma.
Acs B, Szarvas T, Szekely N, Nyirady P, Szasz AM. Acs B, et al. Among authors: nyirady p. Curr Cancer Drug Targets. 2015;15(8):643-51. doi: 10.2174/156800961508151001100829. Curr Cancer Drug Targets. 2015. PMID: 26452381 Review.
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.
Vom Dorp F, Tschirdewahn S, Niedworok C, Reis H, Krause H, Kempkensteffen C, Busch J, Kramer G, Shariat SF, Nyirady P, Rübben H, Szarvas T. Vom Dorp F, et al. Among authors: nyirady p. J Urol. 2016 Apr;195(4 Pt 1):1120-5. doi: 10.1016/j.juro.2015.09.084. Epub 2015 Oct 8. J Urol. 2016. PMID: 26454102
180 results